BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7556446)

  • 1. Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis.
    Mello ML; Contente S; Vidal BC; Planding W; Schenck U
    Exp Cell Res; 1995 Oct; 220(2):374-82. PubMed ID: 7556446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear changes induced in NIH/3T3 cells by transfection and tumorigenesis.
    Mello ML; Russo J
    Cytobios; 1989; 60(242-243):135-49. PubMed ID: 2632149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scanning microphotometry image analysis of Ha-ras-transformed human breast epithelial cells.
    Mello ML; Lin TY; Russo J
    Anal Cell Pathol; 1994 Dec; 7(4):301-19. PubMed ID: 7696155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image analysis of Feulgen-stained NIH/3T3 cells transformed with DNA of 4-nitroquinoline 1-oxide treated human breast epithelial cells.
    Mello ML; Vidal Bde C; Golembieski W; Russo J
    Biochem Cell Biol; 1992 Feb; 70(2):109-16. PubMed ID: 1380816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional inhibition of Ha-ras in interferon-induced revertants of ras-transformed mouse cells.
    Rimoldi D; Samid D; Flessate DM; Friedman RM
    Cancer Res; 1988 Sep; 48(18):5157-62. PubMed ID: 2457435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
    Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
    Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image analysis of Feulgen-stained c-H-ras-transformed NIH/3T3 cells.
    Mello ML; Russo J
    Biochem Cell Biol; 1990; 68(7-8):1026-31. PubMed ID: 2223010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
    Omata-Yamada T; Yamada H; Lengyel P
    J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image analysis of Feulgen-stained transformed NIH 3T3 cells differing in p21 expression and ras-induced metastatic ability.
    Mello ML; Chambers AF
    Anal Quant Cytol Histol; 1994 Apr; 16(2):113-23. PubMed ID: 8043158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
    Shumaker DK; Sklar MD; Prochownik EV; Varani J
    Exp Cell Res; 1994 Oct; 214(2):440-6. PubMed ID: 7925639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
    Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts.
    Hajnal A; Klemenz R; Schäfer R
    Cancer Res; 1993 Oct; 53(19):4670-5. PubMed ID: 7691400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical anisotropy of toluidine blue-stained transformed cell nuclei.
    Mello ML
    Acta Histochem; 1995 Apr; 97(2):159-64. PubMed ID: 7660733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation.
    Zhang JY; Schultz RM
    Cancer Res; 1992 Dec; 52(23):6682-9. PubMed ID: 1423314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation is not involved in the structural alterations of ornithine decarboxylase or total chromatin of c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts.
    Laitinen J; Saris P; Hölttä E
    J Cell Biochem; 1995 Apr; 57(4):670-9. PubMed ID: 7615652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
    Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
    Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative functional study of the lysyl oxidase promoter in fibroblasts, Ras-transformed fibroblasts, myofibroblasts and smooth muscle cells.
    Reynaud C; Gleyzal C; Jourdan-Le Saux C; Sommer P
    Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1237-47. PubMed ID: 10643973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatin supraorganization, mitotic abnormalities and proliferation in cells with increased or down-regulated lox expression: Indirect evidence of a LOX-histone H1 interaction in vivo.
    Mello ML; Alvarenga EM; Vidal Bde C; Di Donato A
    Micron; 2011 Jan; 42(1):8-16. PubMed ID: 20888776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
    Fujita H
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on alterations of gene expression in a flat revertant R1 from ras-oncogene transformed NIH/3T3 cells].
    Müllauer L
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):705-16. PubMed ID: 7693563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.